** Shares of U.S.-listed healthcare firms based in or with operations in Israel down 4%-12% premarket amid military conflict in the Middle East

** U.S.-listed shares of Teva Pharmaceutical , the world's largest generic drugmaker, drops 4%

** Shares of Gamida Cell down ~10%, Vascular Biogenics slide 8.2%, IceCure Medical fell 12.2%

** Protalix BioTherapeutics down 5.5% despite a statement saying it does not anticipate a disruption in supply of Elelyso, which treats a rare genetic disorder

** Other U.S.-listed shares of healthcare firm such as BioLineRX , InterCure , Can-Fite BioPharma

are down nearly 7%

(Reporting by Khushi Mandowara in Bengaluru)

((Khushi.Mandowara@thomsonreuters.com;))